InfraRed Capital Partners has successfully completed the sale of its investment in Celsus Holding Pty Ltd, managing the Royal Adelaide Hospital, reinforcing its commitment to sustainable healthcare practices.
Information on the Target
InfraRed Capital Partners has successfully completed the sale of its investment in Celsus Holding Pty Ltd, which operates the Royal Adelaide Hospital (RAH) Public-Private Partnership (PPP). The RAH is considered South Australia’s flagship healthcare institution, notable for being one of the most technologically advanced hospitals in Australia. Since its operational commencement in 2017, it has been integral in providing a comprehensive range of medical services to a vast number of patients; serving approximately 85,000 inpatients and 400,000 outpatients each year across its 800-bed facility.
This state-of-the-art hospital, built under a 35-year PPP agreement with the South Australian Government, is managed by SA Health. InfraRed played an essential role in the development and construction phases of the RAH, applying its extensive experience in healthcare and infrastructure management. They also facilitated connections between the RAH and other UK healthcare facilities within their portfolio to share best practices and established Environmental, Social, and Governance (ESG) measures from the project's inception.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in South Australia
The healthcare sector in South Australia is characterized by a robust infrastructure and a commitment to high-quality clinical services. As one of the primary health service providers, the RAH underscores the State's commitment to modern healthcare delivery. The establishment of advanced facili
Similar Deals
Medtronic plc → Anteris Technologies Global Corp.
2026
Medtronic, plc → Anteris Technologies Global Corp.
2026
Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LP → Medline, Inc.
2025
Flerie Invest AB → Nanologica AB (publ)
2025
InfraRed Capital Partners
invested in
Celsus Holding Pty Ltd
in 2023
in a Public-to-Private (P2P) deal